References
Seki N, Sakamoto S, Karube Y, Oyaizu T, Ishihama H, Chida M. 18F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival. Ann Nucl Med. 2014. doi:10.1007/s12149-014-0804-2.
Lococo F, Cesario A, Okami J, Cardillo G, Cavuto S, Tokunaga T, Apolone G, Margaritora S, Granone P. Role of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade of thymic epithelial tumors: a multicenter analysis. Lung Cancer. 2013;82:245–51.
Adams MC, Turkington TG, Wilson JM, Wong TZ. A systematic review of the factors affecting accuracy of SUV measurements. Am J Roentgenol. 2010;195:310–20.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chida, M., Sakamoto, S. Reply to ‘Is it time to validate the prognostic role of F-18-FDG PET/CT scan in thymic epithelial tumors?’. Ann Nucl Med 28, 595–596 (2014). https://doi.org/10.1007/s12149-014-0848-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12149-014-0848-3